HSBC MSCI CHINA ETF (CNY) Quote

Up 60 now. It's a lot.

No. Two mistakes in one. lol

Jeunke, I respect you very much, but my expectations are a little bit higher... It's almost (for me) seven years that I hear the Common word 'NDA'... After that 'ubiquitous'... That's more than enough for everyone I presume. They have the best tech, geological the best position, the fastest speed, t

Jeunke,

Thanks for your quick response. I understand. The reality is that the "silence" is the killer for us all LOL......

It sucks that even though we are working with 3 foundries......1 in Singapore, 1 in USA and 1 in Europe....... but nothing has moved the needle YE

It seems to me that the FDA NDA filing will occur before the EMA renders a decision. My guess is Anavex will wait until the MAA is accepted and past the first stop clock so it will have an understanding of what the regulators want that is not in the original filing. With that knowledge in hand Anav

LOLOLOL!! Of course not! CMKX was the biggest penny scam of the first decade of the century.

Did you mean to post on this board?

It’s 6 million ( as a minimum I assume), not 60 millions. Creating breathing space for the company and a bargain for some old and new investors.

Terrible. Is the SEC as crook as it appears to be from an outsider's read of that.

MONDAY - are you prepared and ready? :-)

https://www.barchart.com/stocks/quotes/AITX/overview

This week we will see a sudden RUN.

The AITX website: https://aitx.ai/



GLTA!

Keep reading. I found the reference. And really, don't miss this:

https://www.youtube.com/watch?v=YE1f3n_n9UA

Isaiah 41:10 So do not fear, for I am with you; do not be dismayed, for I am your God.
I will strengthen you and help you; I will uphold you with my righteous right hand.

shucks

Donald Trump’s Odds Of Election Victory Have Suddenly Gone Into Free Fall



Donald Trump and Kamala Harris are entering the final days of their race for the White House, with Tesla billionaire Elon Musk warning of a "financial emergency."

Trump, who recen

Absolutely!

I have no other info than you guys. I am still hoping for news in the next few weeks and before year end. At a minimum I expect an explanation where they stand on their time line plan for 2024/2025.

I can totally relate to that! Beer and left over Halloween candy are about to be considered comfort food until Wednesday!

Interesting AGM coming... 

That might make sense for a well funded company. Alas, Northwest is not a well funded company.

If they filed with the FDA and the FDA requested an additional trail it would put Northwest in possibly a terminal situation.

Much better to reduce the risk as much as possibl

I get where you are coming from. I mean really, who cares that filings are delinquent leaving shareholders in the dark on metrics such as revenue, cogs, balance sheet etc. Who cares that the otc has applied the “yield” sign against snpw - they are probably just a Muppet and part of the fraud you c

Hi Jeunke,

Always look forward to your posts. Quick question. In your opinion do you believe that we will get some news before the end of the year? Or is it a more likely a possibility that things are delayed. Not sure what to make of the fact that we are already in first week of Nove

Thanks for that comparison between ANIP and TGTX, JTFM. We own 1000 shares of ANIP in a taxable account, but I now wonder whether 300 shares of TGTX in cash-poor IRA is enough to take appropriate advantage of that projected growth shown by data in your message. At age 87, I think I have time to sell

This is long, but terrific. Pete is very patient:

https://www.youtube.com/watch?v=YE1f3n_n9UA

China imports lithium niobate, primarily from countries like Brazil and Australia for processing and own use and for re export. This dependence creates also vulnerabilities in supply chains for China itself. Both Australia and Brazil are in principle sources, but processing into a usable material f

Our FDA delay is very likely to focus on the EMA, and then leverage that effort into the similar FDA submission.

My bet is that a prior EMA regulatory approval would have considerable weight in the FDA's deliberations surrounding Blarcamesine. For multiple obvious reasons that have